A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation

(2022) Marika Watanabe et al.   Vaccines

Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers

(2022) Benjamin Bonnet et al.   Frontiers in Immunology

Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients

(2022) Xi Wu et al.   Journal of Hematology & Oncology

Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis

(2022) Chenghao Ge et al.   Experimental Hematology & Oncology

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

(2021) Akshay Sharma et al.   Lancet Haematology

Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan

(2021) Kazuo Imai et al.   JOURNAL OF MEDICAL VIROLOGY

Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients—Room for Improvement and Much to Learn

(2021) Joshua A. Hill   JAMA Network Open

Effectiveness of the BNT162b2mRNA Covid-19 Vaccine in Patients with Hematological Neoplasms

(2021) Moshe Mittelman et al.   BLOOD

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

(2021) Alexis Maillard et al.   BLOOD

Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients

(2021) Immacolata Attolico et al.   BRITISH JOURNAL OF HAEMATOLOGY

Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients

(2021) Lorenzo Canti et al.   Journal of Hematology & Oncology

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

(2021) Rabah Redjoul et al.   Lancet Haematology

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION